Skip to main content

Smoking parents = fat, bad kids

 

Two new studies suggest there's a connection between parents who smoke and kids who are heavier or misbehave more than other children.

The researchers haven't definitively proven that lighting up puts kids at risk for bad behaviour and extra pounds. In fact, it may be impossible to ever prove a cause-and-effect because it's considered unethical to assign some parents to smoke and then see what happens.

Still, the findings "tighten the link" between parents who smoke and physical and mental health problems in their kids, said Dr Jonathan Winickoff, an associate professor of pediatrics at Massachusetts General Hospital, who co-wrote a commentary accompanying the research.

For decades, doctors have advised pregnant women to avoid smoking for fear that they would harm their unborn children; research has linked smoking in mothers to physical problems in offspring such as low birth weight. If the mother smokes during the first trimester, the effects are worse than in later trimesters, said Neil E. Grunberg, a professor of medical and clinical psychology at the Uniformed Services University of the Health Sciences, in Bethesda, Md.

But it hasn't been as clear whether there's a connection between mothers who smoke and other health problems in their kids. And the influence of fathers who smoke - exposing their kids to secondhand smoke or perhaps affecting sperm at conception - has also remained a mystery.

The study

In one of the new studies, researchers examined what happened to kids whose fathers smoked but their mothers did not. Researchers from the University of Hong Kong studied 7,924 kids from that region who were born in 1997.

The researchers found that the kids who had fathers who smoked were more likely to be heavier at ages seven or 11 after the statistics were adjusted so they wouldn't be thrown off by factors such as gender and socioeconomic status.

The study appears in the July print issue of Paediatrics, as does a study linking pregnant mothers who smoke to misbehaving kids.

The second study

In that second study, British and Brazilian researchers studied 509 children in Brazil and 6 735 in England. After adjusting their statistics to account for possible confounding factors, they discovered that kids of mothers who smoked while pregnant were more likely to be deemed aggressive and disruptive.

This isn't the first time researchers have come to this conclusion, said Grunberg. And if smoking does cause the problems, the study doesn't say how, he added.

So, what might be the connection between parents who puff cigarettes and kids who misbehave and weigh more than others?

Winickoff, co-author of the commentary, said it's not true that smoking makes people skinnier. Instead, it boosts the weight around their bellies and hips, he explained. One theory is that secondhand smoke could do the same thing to those who are exposed, like the kids of dads who light up.

As for pregnant mothers who smoke, their bodies don't act as filters, he said. Instead, the toxins from smoking affect the foetus.

"Anyone who's been in the delivery room when a mother who smokes cigarettes delivers can attest to the state of the placenta," he explained. "In general, it's withered, discoloured. It's very clear that the blood supply to the child is compromised." - (HealthDay News, June 2010)



Comments

Popular posts from this blog

ICH GCP requires EC members to be independent of investigator and sponsor to avoid conflicts of interest

Can an Ethics Committee member e.g. layman/chairman or anyone in the committee participate in the trial as a subject? Vidya If an Ethics Committee member becomes a trial subject on a trial that he/she was involved in approving then there has been a major conflict of interest. The following situations need to be considered: ● IEC member reviews study without any prior knowledge of the study, votes, and then afterwards is approached by clinical research team to participate. Possibly this is OK but the member should no longer be part of the IEC that reviews that study. This will be difficult in practice, so therefore it is not advisable. ● IEC member already knows about the study and is voting in order to be able to participate. This is clearly not acceptable and made worse if there is additional financial incentive for the study (e.g. volunteer study). ICH GCP requires Ethics Committee members to be independent of the investigator and the sponsor to avoid confl...

Indian government outlines policies on drug pricing to favor poorer patients, and increase clinical trials

The Indian government is looking to review the existing drug price control measures in order to make medicines more affordable in the country, and at increasing the number of clinical trials taking place in the country, reports The Pharma Letter's India correspondent. In a parallel move, the Health Ministry is also preparing a framework for public private partnership to tackle the menace of non-communicable diseases in the country, In a move that could potentially result in affordable Medicare and health security moving to a larger section of the population, the government is considering a rash of policy measures in favor of poor patients. Talks are also on in government circles to abolish clinical trials on proven drugs that have been approved and marketed for at least two years in the European Union, United States, UK, Australia, Canada and Japan. A draft proposal in this regard has been prepared by the Health Ministry. If instituted, it would reduce the time taken to introduce n...

The polypill: Medicine's magic bullet

The capsule costs pennies, contains a simple cocktail of medicines, and halves the number of strokes and heart attacks. Doctors want to hand it out in the first mass medication for the middle-aged in Britain. So why are the big drug companies so uninterested? The magic bullet, containing five medicines in a single capsule, sharply reduced cholesterol and blood pressure levels and has the potential to "halve cardiovascular events in average middle-aged individuals", the researchers say. The finding is a major boost for a medication with huge potential against the worldwide epidemic of heart disease and stroke. Doctors say that, if further trials prove successful, all men aged over 50 and women aged over 60 should be offered the pill in what would be the first example of mass medication for the middle-aged in Britain. Yet no Western pharmaceutical company has shown interest in developing the so-called polypill because it does not promise big profits. It would sell for pennies b...